A Clinical Study of Darcilil Combined With AI Combined With Pyrrotinib in the Treatment of TPBC
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms
Interventions: DRUG: Darcilide +AI (letrozole/anastrozole/Exemestane) + pyrrotinib
Sponsor: Second Affiliated Hospital of Soochow University